IGHE and Friedreich ataxia: Thus, the purpose of this study was to offer clinicians an inclusive look at IgE-mediated FA patient experiences, including (1) the natural history of FA, including signs and symptoms, health system experiences, and pathways to diagnosis; (2) the burden of disease and psychosocial impact of FAs on individuals and families; (3) perspectives on meaningful treatment attributes and benefits, and clinical trial participation; and (4) topics patients and caregivers would like to learn more about and resources that they use to navigate FAs.